FertilAI, a fertility technology company developing AI-powered clinical decision support tools, has raised $4.5 million in seed funding. The round was co-led by Longevity Venture Partners and Redseed, with participation from angel investors. The Israeli company’s Fertilane platform integrates with clinic electronic medical records (EMRs) to optimize fertility treatments through AI-driven insights. The technology supports various aspects of the fertility journey, from…
Amazon has ended a confidential four-year initiative to develop an at-home fertility monitoring device and companion app, according to a CNBC report. The project, codenamed “Encore,” emerged from Amazon’s 2020 acquisition of bluDiagnostics, a Wisconsin-based startup. The technology aimed to analyze saliva samples to measure fertility hormones estradiol and progesterone, with results viewable through a smartphone app. The project was housed within…
India IVF, a tech-enabled fertility provider, has secured $1.25 million in pre-Series A funding from Tomorrow Capital. This marks the company’s first external investment since its founding in 2014 by Dr. Richika Sahay and Dr. Somendra Shukla, following a decade of profitable operations across five North Indian centers. The investment aims to support India IVF’s expansion across North India, addressing critical gaps…
Fellow Health, a provider of mail-in semen analysis services, has announced it has delivered over 100,000 patient test results since its product launch in 2020. The company reports its testing volume has increased by more than 50% year-to-date from 2023. The company’s mail-in semen analysis service aims to improve access to male fertility testing, addressing a market where 1 in 6 couples…
Parallel Fluidics, a company developing on-demand microfluidic manufacturing solutions with applications in IVF and other life science fields, has secured $7 million in seed funding. The round was led by J2 Ventures with participation from 8VC and Praxis. The company’s technology is already making waves in the fertility sector. Overture Life, a startup focused on simplifying IVF procedures, is utilizing Parallel Fluidics’…
Femasys has announced a strategic partnership with Boston IVF to offer FemaSeed, its FDA-cleared intratubal insemination product, across Boston IVF’s network of nearly 30 fertility centers in the U.S. The collaboration aims to expand access to alternative fertility treatment options before patients progress to more invasive procedures. “We are elated to welcome Boston IVF, a prominent conglomerate in the infertility space, to…
Extend Fertility has released the results of an 8-year comprehensive study on egg freezing success rates, providing new insights into the effectiveness of fertility preservation. The findings, presented at the American Society of Reproductive Medicine Conference in Denver, demonstrate significant success rates and changing trends in egg freezing demographics. The study, which followed 3,100 unique patients through 4,600 egg freezing cycles between…
In what could mark a significant shift in fertility treatment, Celmatix has announced the nomination of its first lead compound in its oral Follicle Stimulating Hormone receptor (FSHR) agonist drug development program. The breakthrough, announced during the American Society for Reproductive Medicine (ASRM) annual meeting in Denver, could potentially transform fertility treatments by replacing traditional hormone injections with oral medications. The development…
